Crystallization (Comment) | Organism |
---|---|
in complex with inhibitors 2-amino-4-(methylthio)-1-(1,3-thiazol-2-yl)butan-1-one, 2-amino-4-(methylthio)-1-pyridin-2-ylbutan-1-one, and 3-amino-1-(cyclopropylamino)heptan-2 | Staphylococcus aureus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-amino-4-(methylthio)-1-(1,3-thiazol-2-yl)butan-1-one | 50% inhibition at 0.019 mM, formation of uncleavable tetrahedral intermediate upon binding | Staphylococcus aureus | |
2-amino-4-(methylthio)-1-pyridin-2-ylbutan-1-one | 50% inhibition at 0.016 mM, formation of uncleavable tetrahedral intermediate upon binding | Staphylococcus aureus | |
3-amino-1-(cyclopropylamino)heptan-2 -one | 50% inhibition at 0.007 mM, formation of uncleavable tetrahedral intermediate upon binding | Staphylococcus aureus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Staphylococcus aureus | P0A080 | isoform I | - |